Flagship Pioneering Fund VI General Partner LLC's Net Worth
$211 Million
Who is Flagship Pioneering Fund VI General Partner LLC?
Flagship Pioneering Fund VI General Partner LLC has an estimated net worth of $211 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Omega Therapeutics, Inc., and Seres Therapeutics, Inc..
SEC CIK
Flagship Pioneering Fund VI General Partner LLC's CIK is 0001724957
Past Insider Trading and Trends
2021 was Flagship Pioneering Fund VI General Partner LLC's most active year for acquiring shares with 13 total transactions. Flagship Pioneering Fund VI General Partner LLC's most active month to acquire stocks was the month of July. 2021 was Flagship Pioneering Fund VI General Partner LLC's most active year for disposing of shares, totalling 15 transactions. Flagship Pioneering Fund VI General Partner LLC's most active month to dispose stocks was the month of July. 2021 saw Flagship Pioneering Fund VI General Partner LLC paying a total of $19,999,973.00 for 57,944,228 shares, this is the most they've acquired in one year. In 2021 Flagship Pioneering Fund VI General Partner LLC cashed out on 119,347,583 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sana Biotechnology, Inc. (SANA) Snapshot price: $6.155
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -32.03% | -11.78M |
—
|
—
| 25M |
Sep 13
| |||
Form 4
|
∞
| 34.24M |
—
|
—
| 34.24M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Omega Therapeutics, Inc. (OMGA) Snapshot price: $3.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 23.71M |
$17.00 |
—
| 23.71M |
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Seres Therapeutics, Inc. (MCRB) Snapshot price: $1.0244
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -39.84% | -7.91M |
—
|
—
| 11.94M |
Nov 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||